Viking Holdings Ltd. is banking on affluent customers to see it through this period of jitters in the travel industry.

Viking Holdings (NYSE:VIK) reports robust Q4 growth with a 20.5% sales surge and plans to expand in 2025. Discover key ...

Viking Therapeutics Inc.’s stock soared 8% Wednesday, after the maker of a promising weight-loss pill secured a manufacturing ...

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

An exhibition delving into the legacy of the Vikings on the Isle of Man has opened. The display at Rushen Heritage Centre ...

Key Takeaways Viking Holdings shares dropped Tuesday as executives warned of macroeconomic "uncertainties" on the cruise ...

Greenland is having a moment in the international spotlight as U.S. President Donald Trump maneuvers to gain control of the ...

Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...

Archaeologists from the Stockholm Shipwreck Museum hope to secure funding for further research and excavation of the ...

Viking launches its 108-page 2025-2027 World Voyages Collection brochure featuring a range of extended travel itineraries.

Today, Benzinga's options scanner spotted 8 options trades for Viking Therapeutics. This is not a typical pattern. The ...

Goldman Sachs analyst Lizzie Dove reiterated a Neutral rating on the shares of Viking Holdings Ltd (NYSE:VIK) and raised the ...